< previous page page_417 next page >

Page 417
6b27ea5dd5e96f455dc5e88e0ec2d831.gif
102. N. Kioka et al., ''Quercetin, a Bioflavonoid, Inhibits the Increase of Human Multidrug Resistance. Gene (MDR1) Expression Caused By Arsenite,'' FEBS Letters 301 (3): 307-9 (1992).
6b27ea5dd5e96f455dc5e88e0ec2d831.gif
103. G. Elia and M.G. Santoro, "Regulation of Heat Shock Protein Synthesis by Quercetin in Human Erythroleukemia Cells," Biochemical Journal 300 (Pt. l): 201-9 (1994).
6b27ea5dd5e96f455dc5e88e0ec2d831.gif
104. M. Koishi et al., "Quercetin, an Inhibitor of Heat Shock Protein Synthesis, Inhibits the Acquisition of Thermotolerance in a Human Colon Carcinoma Cell Line," Japanese Journal of Cancer Research 83 (11): 1216-22 (1992).
6b27ea5dd5e96f455dc5e88e0ec2d831.gif
105. G. Scambia et al., "Quercetin Potentiates the Effect of Adriamycin in a Multidrug-resistant MCF-7 Human Breast Cancer Cell Line: P-glycoprotein As a Possible Target," Cancer Chemotherapy and Pharmacology 34 (6): 459-44 (1994).
6b27ea5dd5e96f455dc5e88e0ec2d831.gif
106. M. Piantelli et al., "Tamoxifen and Quercetin Interact with Type II Estrogen Binding Sites and Inhibit the Growth of Human Melanoma Cells," Journal of Investigative Dermatology 105 (2): 248-53 (1995).
6b27ea5dd5e96f455dc5e88e0ec2d831.gif
107. J. Boik, Cancer and Natural Medicine (Princeton, Minn.: Oregon Medical Press, 1995), 151-53.
6b27ea5dd5e96f455dc5e88e0ec2d831.gif
108. H. Wei et al., "Inhibitory Effects of Apigenin, a Plant Flavonoid, on Epidermal Ornithine Decarboxylase and Skin Tumor Promotion in Mice," Cancer Research 50 (3): 499-502 (1990).
6b27ea5dd5e96f455dc5e88e0ec2d831.gif
109. D.F. Birt et al., "Anti-mutagenesis and Anti-promotion by Apigenin, Robinetin and Indole-3-carbinol," Carcinogenesis 7 (6): 959-63 (1986).
6b27ea5dd5e96f455dc5e88e0ec2d831.gif
110. M. Hertog et al., "Intake of Potentially Anticarcinogenic Flavonoids and Their Determinants in Adults in the Netherlands," Nutrition and Cancer 20 (1): 21-49 (1993).
6b27ea5dd5e96f455dc5e88e0ec2d831.gif
111. M.E. Begin et al., "Differential Killing of Human Carcinoma Cells Supplemented with n-3 and n-6 Polyunsaturated Fatty Acids," Journal of the National Cancer Institute 77 (5): 1053-62 (1986).
6b27ea5dd5e96f455dc5e88e0ec2d831.gif
112. C.E van der Merwe et al., "Oral Gamma-Linolenic Acid in 21 Patients with Untreatable Malignancy. An Ongoing Pilot Open Clinical Trial," British Journal of Clinical Practice 41 (9): 907-15 (1987).
6b27ea5dd5e96f455dc5e88e0ec2d831.gif
113. M.E. Begin et al., "Selective Killing of Human Cancer Cells by Polyunsaturated Fatty Acids," Prostaglandin and Leukotriene Medicine 19 (2): 177-86 (1985).
6b27ea5dd5e96f455dc5e88e0ec2d831.gif
114. M. Nakagawa et al., "Potentiation by Squalene of the Cytotoxicity of Anticancer Agents Against Cultured Mammalian Cells and Murine Tumor," Japanese Journal of Cancer Research 76 (4): 315-20 (1985).

 
< previous page page_417 next page >

If you like this book, buy it!